A Brief History of Allergies: From Hay Fever to the Hygiene Hypothesis

A brief history of allergies traces a 2,000-year arc from ancient observations of "rose fever" to a modern epidemic affecting roughly 1 in 3 adults worldwide. The core insight: allergies are not a malfunction but a misdirected immune response, where IgE antibodies built to fight parasites instead target harmless proteins like pollen and peanut. This history shows how a disease once so rare that 19th-century doctors debated its existence became a defining condition of industrialized life, rising in lockstep with urbanization, cleaner water, and smaller families.

What an Allergic Reaction Actually Is: The IgE Mechanism

Before the history, the biology. An allergy begins when an antigen-presenting cell takes up an allergen and shows it to a naive T helper cell, which releases interleukin-4 and drives B cells to switch to producing immunoglobulin E. This IgE binds the surface of mast cells and basophils. On a second exposure, the allergen cross-links two IgE molecules, and the cell degranulates within minutes, releasing histamine, tryptase, and leukotrienes.

That immediate phase produces sneezing, hives, and bronchoconstriction. A second, late phase arrives 4 to 8 hours later, driven by eosinophils and lasting up to 24 hours. This two-phase architecture explains why a reaction can seem to fade and then return. It is the reason a child given peanut at noon can still be symptomatic at midnight.

In plain terms: IgE is a loaded trap, and each allergen encounter springers it.

The counterintuitive part is that IgE evolved as an anti-parasite weapon. Its affinity for worm surface proteins is exquisitely tuned. The allergic response is that same weapon firing at the wrong target. Why the immune system mistakes pollen for a worm is the central mystery the history below has been trying to solve.

The Timeline: Two Centuries of Allergy Science

The 28 patients in Bostock's 1819 paper are a clue in themselves. Hay fever was then rare enough that a single physician could catalog nearly every case in London. Von Pirquet's 1906 coinage, meaning "altered reactivity," originally referred to any immune reaction, protective or harmful. The narrowing of the word to "bad reaction" happened over the following decades.

The Numbers: From Rarity to Epidemic

Allergy prevalence in the 19th century is impossible to measure precisely, but the historical record is unambiguous about its scarcity. Bostock reported that summer catarrh affected a small, largely aristocratic subset. Modern prevalence is a different world.

• Roughly 25 to 30 percent of adults in the United States report at least one allergy, per 2021 CDC data.
• Food allergy affects about 8 percent of US children, up from an estimated 3 to 4 percent in the 1990s.
• Asthma, the respiratory cousin, affects about 8 percent of US adults and 7 percent of children.
• Anaphylaxis hospitalization rates in the US rose roughly 3-fold between 1998 and 2018.

The scale matters more than any single figure. A disease that was a medical curiosity in 1819 now touches a third of the population. This rise happened too fast for genetic change alone, which points squarely at environment.

The Hygiene Hypothesis and Its Refinements

In 1989, David Strachan analyzed 17,414 British children born in a single week and found that hay fever risk fell with each additional older sibling and rose with household sharing of drinking cups. His explanation: early exposure to germs through siblings trains the immune system away from allergic overreaction.

The 2002 "old friends" hypothesis sharpened this. It isn't childhood infections that matter but constant exposure to largely harmless microbes and parasites that co-evolved with humans. These exposures drive regulatory T cells that keep IgE responses in check. Strip them away and the brake is released.

The mechanism is now fairly well characterized: without regulatory T cell training, Th2 responses go unbalanced. This is established science. What remains hypothesis is the exact dose and timing required, and why some children with clean environments escape allergy entirely. The counterintuitive edge case is that a little farming dust protects, while a lot of air pollution worsens. The immune system is not responding to "dirt" as a quantity but to specific microbial signals.

Quantifying the Risk: What Predicts Allergy

Read this table with care. A 20 percent relative risk change sounds large but translates to a small absolute difference at the population level. No single environmental factor explains the epidemic; the effect is cumulative and probabilistic.

The Peanut Story: A Corrected Misconception

For two decades after 1990, pediatric guidelines advised delaying peanut introduction until age 3 for high-risk children. This advice was well-intentioned and, it turned out, backwards.

The 2015 Learning Early About Peanut Allergy (LEAP) trial assigned 640 high-risk infants to either eat peanut regularly or avoid it, then measured allergy at age 5. Among infants with severe eczema or egg allergy, early consumption cut peanut allergy by 81 percent. The number was so large the trial stopped early.

Why did avoidance backfire? The leading hypothesis is that immune exposure through inflamed skin, as in eczema, sensitizes rather than tolerates. Eating peanut early, through the gut, teaches tolerance. This is the most important correction in allergy history: the advice to avoid made the disease worse. Current guidance, per the 2017 US addendum to the 2010 NIAID guidelines, recommends introducing peanut around 4 to 6 months in high-risk infants after evaluation. It is one of the rare cases where a scientific consensus reversed itself decisively.

Variations: How Allergy Differs Across Populations

Allergy is not one disease. The mechanism is shared, but the expression varies sharply by geography, age, and genetics.

The "allergic march" describes the typical progression: eczema in infancy, then food allergy, then allergic rhinitis, then asthma by school age. Roughly half of children with early eczema go on to develop asthma, though most outgrow the eczema.

Geography matters too. Food allergy prevalence is far higher in the US and UK, reaching 8 to 10 percent of children, than in much of Asia and southern Europe, where it is often 1 to 3 percent. This gradient is too steep for genetics alone and supports the environmental explanation. Meanwhile, asthma is more common in some urban populations that also have high pollution, which adds a separate irritant pathway on top of the immune one.

Age of onset also splits the population. Adult-onset allergy, especially to shellfish and new environmental triggers, is common and often mistaken for intolerance. And some allergies fade: roughly 80 percent of young children with milk or egg allergy outgrow it by school age, while peanut and tree nut allergies are far more persistent, with only about 20 percent resolving.

What to Actually Do: Practical Actions Backed by Evidence

If you are trying to reduce allergy risk in a child, the evidence points in specific directions.

• Introduce peanut and other common allergens around 4 to 6 months in high-risk infants, after discussing with a clinician.
• Treat moderate-to-severe eczema aggressively and early; inflamed skin is a sensitization route.
• Do not delay allergenic foods based on family history alone; the old advice reversed.
• Breastfeed if you can, though its protective effect on allergy is modest and inconsistent across studies.
• For established allergy, carry epinephrine if anaphylaxis is possible and use it at the first sign of airway or cardiovascular symptoms, not as a last resort.

For adults with seasonal allergies, intranasal corticosteroids outperform antihistamines for moderate-to-severe rhinitis, a distinction many people miss because antihistamines act faster and feel more responsive.

Red Flags: When Allergy Is an Emergency

Most allergic reactions are annoying, not dangerous. A small fraction become anaphylaxis, a multisystem emergency that progresses in minutes. Seek emergency care immediately for any of the following.

• Swelling of the tongue, lips, or throat, or a sensation of throat tightness
• Difficulty breathing, wheezing that does not respond to usual medication, or hoarseness
• Dizziness, fainting, or a sense of impending doom
• Widespread hives combined with vomiting or abdominal cramping
• Symptoms that recur hours after apparent recovery, known as biphasic anaphylaxis

Anaphylaxis kills an estimated 1 to 5 people per million per year in industrialized countries. The number is small, which is precisely why prompt epinephrine matters: reaction speed is the variable that separates a scare from a fatality.

The Limits of the Story

The history of allergies is partly a story of ideas outrunning evidence. The hygiene hypothesis is well supported as a general framework but poorly predictive for any individual child. You cannot reliably engineer a protective environment by adding a dog or a sibling.

What the history does establish: allergies rose because environments changed faster than immune systems could adapt, and one major piece of medical advice, the delay of allergen introduction, was simply wrong for a generation. The remaining questions, about which microbial exposures matter and how to reproduce them safely, are still open. One number reconciles the whole narrative: an 81 percent reduction from a single dietary change versus a century of rising prevalence. The lever exists. Finding it for everyone is the next chapter.